IPCA Laboratories Ltd.’s second-quarter profit fell, missing estimates.
The Mumbai-based bulk and formulation drugmaker’s net profit fell 42% year-on-year to Rs 144 crore in the quarter ended September, according to its exchange filing. That compares with the Rs 218-crore consensus estimate of analysts tracked by Bloomberg.
IPCA Laboratories Q2 Highlights (YoY)
Revenue was up 4% at Rs 1,601 crore, against an estimate of Rs 1,655 crore.
Ebitda was down 29% at Rs 261 crore, against the Rs 337-crore forecast.
The margin stood at 16.3% against 23.7%. That compares to the forecast of 20.4%.
Board declared interim dividend of Rs 4 per share
Overall sales from formulations rose 12% year-on-year, while those from bulk drugs fell 15%.
Shares of IPCA Laboratories fell 4.36% as of 1:28 p.m. post earnings, compared with a 1.86% rise in the benchmark S&P BSE Sensex.
RECOMMENDED FOR YOU
![](https://images.assettype.com/bloombergquint/2022-10/47756110-f854-4525-ab99-5b8afa4f509a/Close_view_of_holding_medicines___Photo_Volodymyr_Hryshchenko_Unsplash_.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Ipca Labs Q1 Results Review - Domestic Formulation Drives Earnings: Motilal Oswal
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2022-09/138b91dd-dfd4-471b-82ed-0294cc149c47/Ipca_Labs_formulation_plant___Source_Company_website_.png?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Ipca Labs Q1 Results: Profit, Revenue Meet Estimates On Higher Global Sales
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2023-04/587e409a-b82a-43f2-92d7-510da259b4b4/hannah_morgan_ycVFts5Ma4s_unsplash.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
RattanIndia Enterprises Q1 Result: Net Profit Surges Nearly Five-Fold
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-02/c7c449b2-f59c-4ae5-ba1f-ead81239e8b8/EIH_website.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
EIH Shares Tumble 10% After Q1 Profit Falls, Misses Estimates
![timelogo](/images/amp-time.png)